Zhejiang Xianju Pharmaceutical Co Ltd
SZSE:002332
Dividends
Dividend Yield
Zhejiang Xianju Pharmaceutical Co Ltd
Current Yield | |
Min Yield | |
Max Yield | |
Average Yield | |
Median Yield |
Dividend Per Share
Zhejiang Xianju Pharmaceutical Co Ltd
Payout Ratio
Zhejiang Xianju Pharmaceutical Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Zhejiang Xianju Pharmaceutical Co Ltd is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Zhejiang Xianju Pharmaceutical Co Ltd
Average Annual Return | 0.93% |
Standard Deviation of Annual Returns | 11.63% |
Max Drawdown | -55% |
Market Capitalization | 9.9B CNY |
Shares Outstanding | 989 200 000 |
Percentage of Shares Shorted |
N/A
|
Stock Splits
Zhejiang Xianju Pharmaceutical Co Ltd's latest stock split occurred on May 18, 2017
The company executed a 15-for-10 stock split, meaning that for every 10 shares held, investors received 15 new shares.
Before the split, Zhejiang Xianju Pharmaceutical Co Ltd traded at 12.5801 per share. Afterward, the share price was about 7.6766.
The adjusted shares began trading on May 18, 2017. This was Zhejiang Xianju Pharmaceutical Co Ltd's 2nd stock split, following the previous one in May 8, 2014.